Clinical trial
Combined Therapy of Silymarin and Desferrioxamine in Patients With B-thalassemia Major: a Randomized Double-blind Clinical Trial
NCT00999349 is registered in ClinicalTrials.gov with Isfahan University of Medical Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combined Therapy of Silymarin and Desferrioxamine in Patients With B-thalassemia Major: a Randomized Double-blind Clinical Trial
- Lead sponsor
- Isfahan University of Medical Sciences
- Phase
- Phase 2/3
- Overall status
- Unknown status
- Start date
- March 31, 2009
- Completion date
- Not reported
- Enrollment
- 140 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
beta-thalassemia major, iron overload